Nebula Research & Development LLC Eli Lilly & CO Transaction History
Nebula Research & Development LLC
- $852 Billion
- Q4 2024
A detailed history of Nebula Research & Development LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Nebula Research & Development LLC holds 4,097 shares of LLY stock, worth $3.81 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
4,097
Previous 2,459
66.61%
Holding current value
$3.81 Million
Previous $2.18 Billion
45.18%
% of portfolio
0.37%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
4,278Shares Held
757MCall Options Held
10.2MPut Options Held
11.4M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$90.1 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA74.2MShares$69 Billion1.03% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$61.2 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.3MShares$47.7 Billion26.72% of portfolio
-
State Street Corp Boston, MA34.3MShares$31.9 Billion1.07% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $883B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...